PCN46 ECONOMIC EVALUATION OF ONCOTYPE DX TO TARGET CHEMOTHERAPY USE IN LYMPH-NODE-NEGATIVE, OESTROGENRECEPTOR-POSITIVE, EARLY-STAGE BREAST CANCER IN IRELAND
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)71942-8
https://www.valueinhealthjournal.com/article/S1098-3015(11)71942-8/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
98
First Page :
A259
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71942-8&doi=10.1016/S1098-3015(11)71942-8